William P. Kane Jr. - 28 Dec 2023 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Chief Commercial Officer
Signature
/s/ Mia Kelley, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Dec 2023
Net transactions value
-$1,210,796
Form type
4
Filing time
29 Dec 2023, 16:43:40 UTC
Previous filing
07 Feb 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Tax liability $1,210,796 -3,828 -22% $316.30 13,828 28 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting of restricted stock units previously granted to the Reporting Person on February 6, 2023.